Yahoo Finance Today's Research Reports on Trending Tickers: Neovasc and Puma Biotechnology
NEW YORK, NY / ACCESSWIRE / April 30, 2018 / U.S. equities were mixed Friday as strong earnings reports from major companies failed to boost investor's enthusiasm. The Dow Jones Industrial Average dropped 0.05 percent to close at 24,311.19, while the S&P 500 Index rose 0.11 percent to close at 2,669.91. The tech-heavy Nasdaq Composite Index increased 0.02 percent to close at 7,119.80. For the week, the Nasdaq and Dow Jones fell 0.4 percent and 0.6 percent, respectively, while S&P 500 ended 0.01 percent down.
Jack de Gan, chief investment officer at Harbor Advisory Corp., said that while GDP growth remained solid, it had been slow. "I'm worried there may have been an inflection point when Trump started to talk about trade and tariffs. If we start to see more trade tensions, then the idea of 3% growth goes out the window."
RDI Initiates Coverage on:
Neovasc Inc.
https://rdinvesting.com/news/?ticker=NVCN
Puma Biotechnology, Inc.
https://rdinvesting.com/news/?ticker=PBYI
Neovasc's stock moved 5.31% lower Friday, to close the day at $0.04. The stock recorded a trading volume of 87,805,044 shares, which was above its three months average volume of 68,341,358 shares. In the last year, Neovasc's shares have traded in a range of 0.03 - 1.89. The share price has gained 36.67% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.08 is below its 200-day moving average of $0.58. Shares of Neovasc have fallen roughly 33.33 percent in the past month and are down 93.33 percent year-to-date.
Access RDI's Neovasc Inc. Research Report at:
https://rdinvesting.com/news/?ticker=NVCN
On Friday, shares of Puma Biotechnology, Inc. recorded a trading volume of 616,126 shares, which was below the three months average volume of 788,506 shares. The stock ended the day 6.31% higher at $68.25. The share price has fallen 50.15% from its 52 week high with a 52 week trading range of 28.35 - 136.90. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $67.53 is below its 200-day moving average of $87.77. Shares of Puma Biotechnology, Inc. have gained roughly 0.29 percent in the past month and are down 30.96 percent year-to-date.
Access RDI's Puma Biotechnology, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=PBYI
Our Actionable Research on Neovasc Inc. (NASDAQ :NVCN) and Puma Biotechnology, Inc. (NASDAQ :PBYI) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute
SOURCE: RDInvesting.com
